Yam Nicholson, McMullan David Michael
Division of Cardiac Surgery, Seattle Children's Hospital, Seattle, WA, USA.
Ann Transl Med. 2017 Feb;5(4):72. doi: 10.21037/atm.2017.01.11.
Extracorporeal life support (ECLS) is used for patients in isolated or combined cardiopulmonary failures. The use of ECLS to rescue patients with cardiac arrest that is refractory to conventional cardiopulmonary resuscitation has been shown to improve survival in many patient populations. Increasing recognition of the survival benefit associated with extracorporeal cardiopulmonary resuscitation (ECPR) has led to increased use of ECPR during the past decade. This review provides an overview of ECPR utilization; population-based clinical outcomes, resource utilization and costs associated this advanced form of life support therapy.
体外生命支持(ECLS)用于孤立性或合并性心肺衰竭患者。在许多患者群体中,使用ECLS抢救对传统心肺复苏无反应的心脏骤停患者已被证明可提高生存率。在过去十年中,对体外心肺复苏(ECPR)相关生存益处的认识不断提高,导致ECPR的使用增加。本综述概述了ECPR的应用;基于人群的临床结局、资源利用以及与这种先进生命支持治疗形式相关的成本。